Zika virus spread for months before being detected by public health officials, according to genetic analysis. Plus, can fidget spinners really quell symptoms of ADHD and autism?
What US hospitals can learn from the ransomware attack on the UK health care system, plus the latest hurdle for Sarepta's DMD drugs.
A new treatment for ALS gets a green light from the FDA as the NIH prepares to take a deep dive into chronic fatigue syndrome.
A third of the population has experienced "mini" stroke, but most don't know how to handle it. Plus, catch up on the latest drug price controversy for rare-disease drugs.
Did you miss out on AAN? Catch up on the latest science with Neurology Advisor's live coverage, plus learn about the latest FDA approval.
A report ties over 4000 children with birth defects to a popular epilepsy drug, while the FDA issues a stern warning about the use of codeine and tramadol in children.
The latest studies suggest that silencing the SCA2 gene may help reduce symptoms of ALS and deep brain stimulation may quell tics associated with Tourette's syndrome.
Teva's Huntington's chorea drug names a competitive price as other drug makers pursue phase 3 studies in glioblastoma and depression despite disappointing data.
Pricing criticism strikes Roche's Ocrevus as the nominee for FDA commissioner comes under fire for potential conflicts of interest.
The CDC says we should be paying more attention to fall-related concussion prevention in the elderly while one of the NFL's own heads to Harvard for a neurosurgery residency.
Neurology Advisor Articles
- Vitamin D Deficiency Affects Cognition in Multiple Sclerosis
- Telestroke Treatment With IV tPA: How Long Is the Window of Opportunity?
- Hypothalamus May Play a Central Role in Chronic Migraine
- Migraine Attacks Associated With Reduced Dopamine Levels
- Polypharmacy in Schizophrenia May Have Adverse Effect on Cognition
- In MS, Disease Duration, Lesion Load Predict Relapses and Disability Progression
- Ocrelizumab May Improve Cognitive Function in Relapsing Multiple Sclerosis
- Teriflunomide for MS Associated With Low Rates of Infection, Lymphopenia
- The Handoff: Your Week in Neurology News - 5/25/17
- In Multiple Sclerosis, Hand Strength May Indicate Disease Status